(1) Xin Chu1,2ǂ, Han-Shen Tae3ǂ*, Qingliang Xu1,2, Tao Jiang1,2, David J. Adams3 and Rilei Yu1,2,4*.α-Conotoxin Vc1.1 Structure-Activity Relationship at the Human α9α10 Nicotinic Acetylcholine Receptor Investigated by Minimal Side Chain Replacement. ACS Neurochemical Science (Accepted).
(2) Xu X, Liang J, Zhang Z, Jiang T, Yu R*. Blockade of Human α7 Nicotinic Acetylcholine Receptor by α-Conotoxin ImI Dendrimer: Insight from Computational Simulations. Mar Drugs. 2019 May 23;17(5). pii: E303. doi: 10.3390/md17050303.
(3) Rilei Yu1,2*, Han-Shen Tae3, Qingliang Xu1,2, David J. Craik4, David J. Adams3, Tao Jiang1,2 and Quentin Kaas4*. An antagonist-bound structure of the human α4β2 nicotinic acetylcholine receptor. Br J Pharmacol. 2019 Aug;176(15):2750-2763. doi: 10.1111/bph.14698. Epub 2019 Jun 7.
(4) Rilei Yu*, Han-Shen Tae, Nargis Tabassum, Juan Shi, Tao Jiang, and David J. Adams*. Molecular determinants conferring the stoichiometric-dependent activity of α-conotoxins at the human α9α10 nicotinic acetylcholine receptor subtype. J. Med. Chem. May 7, 2018. DOI: 10.1021/acs.jmedchem.8b00115
(5) Fangling Chen, Wenxin Huang, Tao Jiang and Rilei Yu*. Determination of the μ-Conotoxin PIIIA Specificity Against Voltage-Gated Sodium Channels from Binding Energy Calculations. Mar. Drugs 2018, 16(5), 153; https://doi.org/10.3390/md16050153
(6) Yujuan Han1, Rilei Yu1, Gao P, Xinzhi Lu*, Wengong Yu*. The hydrogen-bond network around Glu160 contributes to the structural stability of chitosanase CsnA from Renibacterium sp. QD1. Int J Biol Macromol. 2017 Nov 18. pii: S0141-8130(17)33557-2. doi: 10.1016/j.ijbiomac.2017.11.071.
(7) Ma Q, Tae HS, Wu G, Jiang T, Yu R*. Exploring the Relationship between Nicotinic Acetylcholine Receptor Ligand Size, Efficiency, Efficacy, and C-Loop Opening. J Chem Inf Model. 2017 Aug 28;57(8):1947-1956. doi: 10.1021/acs.jcim.7b00152. Epub 2017 Aug 2
(8) Jiang, L.; Yin, R.; Wang, X.; Dai, J.; Li, J.; Jiang, T*.; Yu, R*. Design and Synthesis of Neolamellarin a Derivatives Targeting Heat Shock Protein 90. Eur. J. Med. Chem. 2017, 135, 24–33.
(9) Yu, R.; Seymour, V. A. L.; Berecki, G.; Jia, X.; Akcan, M.; Adams, D. J.; Kaas, Q.; Craik, D. J. Less Is More: Design of a Highly Stable Disulfide-Deleted Mutant of Analgesic Cyclic α-Conotoxin Vc1.1. Sci. Rep. 2015, 5, 13264.
(10) Yu, R.; Hurdiss, E.; Greiner, T.; Lape, R.; Sivilotti, L.; Biggin, P. C. Agonist and Antagonist Binding in Human Glycine Receptors. Biochemistry (Mosc.) 2014, 53 (38), 6041–6051.
(11) Yu, R.; Kompella, S. N.; Adams, D. J.; Craik, D. J.; Kaas, Q. Determination of the α-Conotoxin Vc1.1 Binding Site on the α9α10 Nicotinic Acetylcholine Receptor. J. Med. Chem. 2013, 56 (9), 3557–3567.
(12) Yu, R.; Kaas, Q.; Craik, D. J. Delineation of the Unbinding Pathway of α-Conotoxin ImI from the α7 Nicotinic Acetylcholine Receptor. J. Phys. Chem. B 2012, 116 (21), 6097–6105.
(13) Yu, R.; Craik, D. J.; Kaas, Q. Blockade of Neuronal α7-nAChR by α-Conotoxin ImI Explained by Computational Scanning and Energy Calculations. PLoS Comput. Biol. 2011, 7 (3), e1002011.